These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28384121)

  • 21. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma.
    Kammerer R; Riesenberg R; Weiler C; Lohrmann J; Schleypen J; Zimmermann W
    J Pathol; 2004 Nov; 204(3):258-67. PubMed ID: 15476270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma.
    Cardillo MR; Lazzereschi D; Gandini O; Di Silverio F; Colletta G
    Anal Quant Cytol Histol; 2001 Apr; 23(2):109-17. PubMed ID: 11332076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.
    Szczepanski MJ; Szajnik M; Welsh A; Whiteside TL; Boyiadzis M
    Haematologica; 2011 Sep; 96(9):1302-9. PubMed ID: 21606166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
    Boström AK; Lindgren D; Johansson ME; Axelson H
    Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
    Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
    Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface engineering of renal cell carcinoma with glycosylphosphatidylinositol-anchored TIMP-1 blocks TGF- β 1 activation and reduces regulatory ID gene expression.
    Notohamiprodjo S; Djafarzadeh R; Rieth N; Hofstetter M; Jaeckel C; Nelson PJ
    Biol Chem; 2012 Dec; 393(12):1463-70. PubMed ID: 23667903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma and natural killer cells: studies in a novel rat model in vitro and in vivo.
    Winter BK; Wu S; Nelson AC; Pollack SB
    Cancer Res; 1992 Nov; 52(22):6279-86. PubMed ID: 1423274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients.
    Gati A; Da Rocha S; Guerra N; Escudier B; Moretta A; Chouaib S; Angevin E; Caignard A
    Int J Cancer; 2004 Apr; 109(3):393-401. PubMed ID: 14961578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
    Schmidt-Wolf IG; Finke S; Trojaneck B; Denkena A; Lefterova P; Schwella N; Heuft HG; Prange G; Korte M; Takeya M; Dorbic T; Neubauer A; Wittig B; Huhn D
    Br J Cancer; 1999 Nov; 81(6):1009-16. PubMed ID: 10576658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL; Doucet M; Brady K; Weber KL
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer.
    Peng LS; Zhang JY; Teng YS; Zhao YL; Wang TT; Mao FY; Lv YP; Cheng P; Li WH; Chen N; Duan M; Chen W; Guo G; Zou QM; Zhuang Y
    Cancer Immunol Res; 2017 Mar; 5(3):248-256. PubMed ID: 28148545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.
    Zhang HG; Kim H; Liu C; Yu S; Wang J; Grizzle WE; Kimberly RP; Barnes S
    Biochim Biophys Acta; 2007 Jul; 1773(7):1116-23. PubMed ID: 17555831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway.
    Chang CT; Hung CC; Chen YC; Yen TH; Wu MS; Yang CW; Phillips A; Tian YC
    Nephrol Dial Transplant; 2008 Apr; 23(4):1126-34. PubMed ID: 18045816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal miRNA Cargo as Mediator of Immune Escape Mechanisms in Neuroblastoma.
    Schmittgen TD
    Cancer Res; 2019 Apr; 79(7):1293-1294. PubMed ID: 30936073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.